PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States. The company's lead product candidate is PDS0101, a Versamune HPV, which is in phase II...
Q1 2026
May 14, 2026
FY 2025
Mar 30, 2026
Q4 2025
Q3 2025
Nov 13, 2025
Q2 2025
Aug 13, 2025